All Posts: breast cancer research
-
Lombardi Women Celebrate Breast Cancer Patients and Researchers
From its humble beginnings 18 years ago with a group of women at the Palm restaurant in Tysons Corner, Lombardi Women: Connecting for a Cure has grown into a fundraising powerhouse, netting more than $5 million in donations for breast cancer research at Georgetown University’s Lombardi Comprehensive Cancer Center. This year’s event was held September 26.
Category: Lombardi Stories
-
ISPY2: A Unique, Flexible Breast Cancer Trial for Modern Times
The ISPY2 breast cancer clinical trial is a unique phase 2 study that offers a broad range of treatment options for patients with locally advanced breast cancer.
Category: Lombardi Stories
-
The Aspirin Conundrum: Navigating Negative Results, Age, Aging Dynamics and Equity
A new study examining the role of aspirin in breast cancer treatment reveals critical issues related to health equity and aging that have broad implications for cancer and other disease intervention trials, say researchers from Georgetown University’s Lombardi Comprehensive Cancer Center. They outline their concerns in an editorial accompanying the study’s findings published April 29 in the JAMA.
Category: News Release
-
Lombardi Women Event Rallies Support for Breast Cancer Research
The 17th Annual Lombardi Women event brought together nearly 400 of the Washington area’s most influential women in support of Georgetown University’s Lombardi Comprehensive Cancer Center and its Nina Hyde Center for Breast Cancer Research.
Category: Lombardi Stories
-
Biology Behind New Drug Used to Treat Triple-Negative Breast Cancer Uncovered
How TTP488 (azeliragon), an experimental drug, impairs aggressive, triple-negative breast cancer from metastasizing has been uncovered at the cellular level, according to researchers at Georgetown University’s Lombardi Comprehensive Cancer Center.
Category: News Release
-
‘Lombardi Women’ Event Brings Together Local Businesswomen to Support Breast Cancer Research
(October 7, 2022) — Held in person for the first time since 2019, the 16th Annual Lombardi Women event brought together 450 businesswomen and 43 sponsoring companies from across the Washington area. The event took place October 6 at the Pavilions at Wolf Trap National Park. “For 16 years, this group of women has come […]
Category: Lombardi Stories
-
New Factors That Can Predict Breast Cancer Recurrence Defined
Discovery Has the Potential to Also Benefit Treatment Choices. WASHINGTON (April 22, 2022) — Genetics and other factors that can determine if a woman is at risk for a recurrence of breast cancer have been identified by investigators at Georgetown Lombardi Comprehensive Cancer Center, providing new research avenues for preventing a new tumor from developing. […]
Category: News Release
-
MRI May Lower Breast Cancer Deaths From Variants in Three Genes
Variants in these genes are as prevalent as the BRCA1/2 mutations. An analysis suggests annual MRI starting at age 30-35 would cut cancer mortality by 50%. WASHINGTON (February 17, 2022) — Annual MRI screenings starting at ages 30 to 35 may reduce breast-cancer mortality by more than 50% among women who carry certain genetic changes […]
Category: News Release
-
Virtual Lombardi Women Event Celebrates 15 Years of Support for Breast Cancer Research
(June 18, 2021) — As fashion editor for The Washington Post, the late Nina Hyde was recognized for her high personal standards and work ethic, as well as her courage and tenacity in dealing with breast cancer. At the 15th anniversary Lombardi Women virtual gathering on June 16, a fundraiser for the Nina Hyde Center […]
Category: Lombardi Stories